Artimplant reports net revenue of SEK 9.7 million for January – June, 2011

Artimplant (STO:ARTIB):

First six months

  • Net revenue amounted to SEK 9.7 million (9.8).
  • The net loss totaled SEK 9.0 million (9.8).
  • Earnings per stock unit amounted to SEK -0.08 (-0.16).
  • The result was affected by one-off items amounting to -0.9 million (-).
  • Artimplant's own sales as a proportion of total sales continued to increase and accounted for 72% (57) of product sales.
  • The Company has revised its cash flow target and the aim now is that a positive cash flow before changes in working capital will be achieved on a monthly basis during the first quarter of 2012 (previously the target was by the end of 2011).

Second quarter

  • Net revenue amounted to SEK 4.3 million (5.1).
  • The net loss totaled SEK 5.2 million (5.0).
  • Earnings per stock unit amounted to SEK -0.04 (-0.08).
  • The result was affected by one-off items amounting to -0.9 million (-).

Events after the period-end

  • Decision has been taken by the Company to open its own sales office in the USA.
Source:

Artimplant

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.